Allison C. Hoffman Sells 3,496 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 3,496 shares of the business’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $25.32, for a total value of $88,518.72. Following the completion of the transaction, the general counsel now directly owns 139,134 shares of the company’s stock, valued at approximately $3,522,872.88. This trade represents a 2.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Phreesia Stock Performance

Shares of PHR stock traded up $1.81 on Wednesday, hitting $29.08. 749,571 shares of the stock traded hands, compared to its average volume of 416,762. The company’s fifty day moving average is $27.32 and its 200 day moving average is $24.00. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53. The company has a market capitalization of $1.71 billion, a PE ratio of -19.78 and a beta of 1.03. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74.

Institutional Trading of Phreesia

Institutional investors and hedge funds have recently modified their holdings of the business. Johnson Financial Group Inc. grew its position in shares of Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after buying an additional 896 shares during the last quarter. R Squared Ltd acquired a new position in Phreesia in the fourth quarter valued at approximately $30,000. BankPlus Trust Department bought a new position in shares of Phreesia during the fourth quarter valued at approximately $34,000. Quarry LP raised its position in shares of Phreesia by 210.9% during the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock worth $71,000 after purchasing an additional 1,923 shares during the period. Finally, Venturi Wealth Management LLC bought a new stake in shares of Phreesia in the 4th quarter worth approximately $76,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have commented on PHR shares. Truist Financial lifted their price target on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Piper Sandler reaffirmed an “overweight” rating and issued a $33.00 target price (up previously from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research note on Thursday, March 13th. Citigroup raised their price target on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Finally, JMP Securities restated a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $31.33.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.